- Release Date: 11/07/14 16:07
- Summary: RELINT: FPH: Disclosure of Directors and Officers Relevant Interests
- Price Sensitive: No
- Download Document 6.67KB
FPH 11/07/2014 16:07 RELINT REL: 1607 HRS Fisher & Paykel Healthcare Corporation Limited RELINT: FPH: Disclosure of Directors and Officers Relevant Interests Name of director or officer of public issuer: Antony John CARTER Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Director B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: "(i) 68 Ordinary Shares (ii) 911 Ordinary Shares" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities "(i) Antony Carter Family Trust No 2 (ii) Loughborough Investments Limited" D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 4 July 2014 Consideration paid for acquisition: "(i) NZ$309.28 (ii) NZ$4,097.43" If the relevant interest was disposed of-- Date of disposal: Not Applicable Consideration received for disposal: Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place: Purchase of 979 Ordinary Shares under the Dividend Reinvestment Plan E Total number of transactions this notice relates to: Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 20 December 2013 Name of director or officer of public issuer: Arthur James MORRIS Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Director B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: 127 Ordinary Shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Niloc Trust D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 4 July 2014 Consideration paid for acquisition: NZ$572.25 If the relevant interest was disposed of-- Date of disposal: Not Applicable Consideration received for disposal: Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place: Purchase of 127 Ordinary Shares under the Dividend Reinvestment Plan. E Total number of transactions this notice relates to: One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 20 December 2013 Name of director or officer of public issuer: Donal Paul O'DWYER Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Director B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: 829 Ordinary Shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Dundrum Super Fund D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 4 July 2014 Consideration paid for acquisition: A$3,219.81 If the relevant interest was disposed of-- Date of disposal: Not Applicable Consideration received for disposal: Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place: Purchase of 829 Ordinary Shares under the Dividend Reinvestment Plan E Total number of transactions this notice relates to: One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 20 December 2013 Name of director or officer of public issuer: Michael Grenfell DANIELL Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Managing Director/Chief Executive Officer B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: "(i) 10,993 Ordinary Shares (ii) 389 Ordinary Shares" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities "(i) Daniell Family Trust (ii) Michael Grenfell Daniell" D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition 4 July 2014 Consideration paid for acquisition "(i) NZ$49,382.83 (ii) NZ$1,749.04" If the relevant interest was disposed of-- Date of disposal Not applicable Consideration received for disposal Not applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place Purchase of 11,382 ordinary shares under the Dividend Reinvestment Plan E Total number of transactions this notice relates to Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer 9 June 2014 Name of director or officer of public issuer: Winston FONG Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Vice President ICT B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities 298 Ordinary Shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities Beneficial Ownership Name of registered holder of securities Winston FONG D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition 4 July 2014 Consideration paid for acquisition NZ$1,339.78 If the relevant interest was disposed of-- Date of disposal Not Applicable Consideration received for disposal Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place Purchase of 298 Ordinary Shares under the Dividend Reinvestment Plan E Total number of transactions this notice relates to One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer 20 December 2013 End CA:00252675 For:FPH Type:RELINT Time:2014-07-11 16:07:43
Ann: RELINT: FPH: Disclosure of Directors and Officers Relevant...
Add to My Watchlist
What is My Watchlist?
